Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 2 |
NetGPI | no | yes: 0, no: 2 |
Related structures:
AlphaFold database: Q4QET1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 58 | 60 | PF00675 | 0.465 |
CLV_NRD_NRD_1 | 70 | 72 | PF00675 | 0.371 |
CLV_PCSK_KEX2_1 | 100 | 102 | PF00082 | 0.415 |
CLV_PCSK_KEX2_1 | 161 | 163 | PF00082 | 0.363 |
CLV_PCSK_KEX2_1 | 58 | 60 | PF00082 | 0.465 |
CLV_PCSK_KEX2_1 | 70 | 72 | PF00082 | 0.376 |
CLV_PCSK_PC1ET2_1 | 100 | 102 | PF00082 | 0.408 |
CLV_PCSK_PC1ET2_1 | 161 | 163 | PF00082 | 0.363 |
CLV_PCSK_SKI1_1 | 146 | 150 | PF00082 | 0.410 |
CLV_PCSK_SKI1_1 | 161 | 165 | PF00082 | 0.316 |
CLV_PCSK_SKI1_1 | 246 | 250 | PF00082 | 0.410 |
CLV_PCSK_SKI1_1 | 274 | 278 | PF00082 | 0.783 |
CLV_PCSK_SKI1_1 | 284 | 288 | PF00082 | 0.678 |
DOC_CDC14_PxL_1 | 264 | 272 | PF14671 | 0.542 |
DOC_MAPK_gen_1 | 56 | 64 | PF00069 | 0.657 |
DOC_MAPK_HePTP_8 | 247 | 259 | PF00069 | 0.296 |
DOC_MAPK_MEF2A_6 | 250 | 259 | PF00069 | 0.296 |
DOC_PP1_RVXF_1 | 244 | 250 | PF00149 | 0.558 |
DOC_PP1_RVXF_1 | 256 | 262 | PF00149 | 0.296 |
DOC_USP7_MATH_1 | 123 | 127 | PF00917 | 0.710 |
DOC_USP7_MATH_1 | 266 | 270 | PF00917 | 0.447 |
DOC_WW_Pin1_4 | 146 | 151 | PF00397 | 0.741 |
LIG_14-3-3_CanoR_1 | 101 | 106 | PF00244 | 0.682 |
LIG_14-3-3_CanoR_1 | 176 | 181 | PF00244 | 0.653 |
LIG_14-3-3_CanoR_1 | 258 | 262 | PF00244 | 0.311 |
LIG_14-3-3_CanoR_1 | 284 | 290 | PF00244 | 0.450 |
LIG_14-3-3_CanoR_1 | 41 | 49 | PF00244 | 0.612 |
LIG_14-3-3_CanoR_1 | 77 | 85 | PF00244 | 0.627 |
LIG_EH1_1 | 126 | 134 | PF00400 | 0.607 |
LIG_eIF4E_1 | 127 | 133 | PF01652 | 0.611 |
LIG_FHA_1 | 108 | 114 | PF00498 | 0.645 |
LIG_FHA_1 | 129 | 135 | PF00498 | 0.591 |
LIG_FHA_2 | 147 | 153 | PF00498 | 0.575 |
LIG_FHA_2 | 41 | 47 | PF00498 | 0.618 |
LIG_FHA_2 | 77 | 83 | PF00498 | 0.618 |
LIG_LIR_Apic_2 | 260 | 266 | PF02991 | 0.340 |
LIG_LIR_Gen_1 | 260 | 268 | PF02991 | 0.296 |
LIG_LIR_LC3C_4 | 131 | 134 | PF02991 | 0.584 |
LIG_LYPXL_yS_3 | 292 | 295 | PF13949 | 0.436 |
LIG_Pex14_2 | 248 | 252 | PF04695 | 0.296 |
LIG_REV1ctd_RIR_1 | 246 | 254 | PF16727 | 0.296 |
LIG_SH2_STAT3 | 127 | 130 | PF00017 | 0.624 |
LIG_SH2_STAT5 | 127 | 130 | PF00017 | 0.635 |
LIG_SH2_STAT5 | 23 | 26 | PF00017 | 0.586 |
LIG_SH2_STAT5 | 29 | 32 | PF00017 | 0.601 |
LIG_SH2_STAT5 | 68 | 71 | PF00017 | 0.612 |
LIG_SH3_2 | 234 | 239 | PF14604 | 0.653 |
LIG_SH3_3 | 189 | 195 | PF00018 | 0.782 |
LIG_SH3_3 | 231 | 237 | PF00018 | 0.661 |
LIG_SUMO_SIM_anti_2 | 131 | 136 | PF11976 | 0.581 |
LIG_SUMO_SIM_par_1 | 130 | 136 | PF11976 | 0.717 |
LIG_TRAF2_1 | 208 | 211 | PF00917 | 0.695 |
MOD_CK1_1 | 107 | 113 | PF00069 | 0.546 |
MOD_CK1_1 | 114 | 120 | PF00069 | 0.539 |
MOD_CK1_1 | 269 | 275 | PF00069 | 0.561 |
MOD_CK1_1 | 83 | 89 | PF00069 | 0.481 |
MOD_CK2_1 | 146 | 152 | PF00069 | 0.453 |
MOD_CK2_1 | 291 | 297 | PF00069 | 0.529 |
MOD_CK2_1 | 40 | 46 | PF00069 | 0.514 |
MOD_CK2_1 | 76 | 82 | PF00069 | 0.513 |
MOD_CMANNOS | 105 | 108 | PF00535 | 0.529 |
MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.477 |
MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.497 |
MOD_GlcNHglycan | 169 | 172 | PF01048 | 0.469 |
MOD_GlcNHglycan | 221 | 224 | PF01048 | 0.556 |
MOD_GlcNHglycan | 31 | 34 | PF01048 | 0.446 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.557 |
MOD_GSK3_1 | 21 | 28 | PF00069 | 0.478 |
MOD_GSK3_1 | 266 | 273 | PF00069 | 0.566 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.524 |
MOD_NEK2_1 | 167 | 172 | PF00069 | 0.454 |
MOD_NEK2_1 | 257 | 262 | PF00069 | 0.305 |
MOD_NEK2_1 | 270 | 275 | PF00069 | 0.481 |
MOD_NEK2_1 | 277 | 282 | PF00069 | 0.512 |
MOD_NEK2_2 | 285 | 290 | PF00069 | 0.567 |
MOD_PIKK_1 | 107 | 113 | PF00454 | 0.558 |
MOD_PIKK_1 | 279 | 285 | PF00454 | 0.603 |
MOD_PKA_2 | 153 | 159 | PF00069 | 0.466 |
MOD_PKA_2 | 257 | 263 | PF00069 | 0.296 |
MOD_PKA_2 | 40 | 46 | PF00069 | 0.514 |
MOD_PKA_2 | 76 | 82 | PF00069 | 0.531 |
MOD_PKA_2 | 96 | 102 | PF00069 | 0.400 |
MOD_Plk_2-3 | 291 | 297 | PF00069 | 0.548 |
MOD_Plk_4 | 128 | 134 | PF00069 | 0.498 |
MOD_Plk_4 | 257 | 263 | PF00069 | 0.306 |
MOD_Plk_4 | 266 | 272 | PF00069 | 0.497 |
MOD_Plk_4 | 80 | 86 | PF00069 | 0.487 |
MOD_ProDKin_1 | 146 | 152 | PF00069 | 0.676 |
TRG_ENDOCYTIC_2 | 292 | 295 | PF00928 | 0.534 |
TRG_ER_diArg_1 | 69 | 71 | PF00400 | 0.497 |
TRG_NLS_MonoExtN_4 | 97 | 104 | PF00514 | 0.506 |
TRG_Pf-PMV_PEXEL_1 | 70 | 75 | PF00026 | 0.539 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IAW0 | Leishmania donovani | 43% | 92% |